Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.39 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9917628 | 1.00 | GLA (0.55) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL9886347 | 1.00 | GLA (0.55) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL7013306 | 0.86 | ALDH1A1 (0.45) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL12086008 | 0.86 | ALDH1A1 (0.45) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL11957431 | 0.86 | GLA (0.53) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL4415882 | 0.86 | ALDH1A1 (0.45) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL22817371 | 0.84 | ALDH1A1 (0.43) | GLAALDH1A1MAPK1L3MBTL1CDC25B | |
| SCHEMBL9191194 | 0.80 | LMNA (0.48) | ALDH1A1 | |
| SCHEMBL7324582 | 0.80 | LMNA (0.48) | ALDH1A1 | |
| SCHEMBL7323991 | 0.80 | LMNA (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117580421-A | Tin-lead mixed perovskite solar cell and preparation method thereof | 中国长江三峡集团有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-109837255-B | Method for chemically modifying ketoamine oxidase | 深圳市安帝宝科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20250263694-A1 | CONJUGATED COMPOSITION AND METHOD FOR DELIVERING A THERAPEUTIC NUCLEIC ACID SEQUENCE TO A LIVING CELL | TWISTER BIOTECH, INC. (US) | 2025-08-21 | — | — | US | disclosed |
| CN-117580421-A | Tin-lead mixed perovskite solar cell and preparation method thereof | 中国长江三峡集团有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117580421-A | Tin-lead mixed perovskite solar cell and preparation method thereof | 中国长江三峡集团有限公司 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023220454-A1 | CONJUGATED COMPOSITION AND METHOD FOR DELIVERING A THERAPEUTIC NUCLEIC ACID SEQUENCE TO A LIVING CELL | TWISTER BIOTECH, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220454-A1 | CONJUGATED COMPOSITION AND METHOD FOR DELIVERING A THERAPEUTIC NUCLEIC ACID SEQUENCE TO A LIVING CELL | TWISTER BIOTECH, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-117054662-A | KIM-1 chemiluminescence kit | 宁波海尔施智造有限公司 | 2023-11-14 | — | — | CN | disclosed |
| EP-4267557-A1 | NOVEL METHOD FOR SYNTHESIZING NCA COMPOUNDS | Ecole Nationale Superieure de Chimie de Montpellier (ENSCM) (FR) | 2023-11-01 | — | — | EP | disclosed |
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-22 | — | — | US | disclosed |
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-22 | — | — | US | disclosed |
| US-20090081458-A1 | Electrostatically bonded polymer vesicle | TOKYO, THE UNIVERSITY OF (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20090081458-A1 | Electrostatically bonded polymer vesicle | TOKYO, THE UNIVERSITY OF (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20080248097-A1 | POLYMERIC MICELLES FOR COMBINATION DRUG DELIVERY | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-09 | — | — | US | disclosed |
| US-20080248097-A1 | POLYMERIC MICELLES FOR COMBINATION DRUG DELIVERY | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-09 | — | — | US | disclosed |
| WO-2008106129-A2 | POLYMERIC MICELLES FOR COMBINATION DRUG DELIVERY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-09-04 | — | — | WO | disclosed |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-03-20 | — | — | US | disclosed |
| US-7316811-B2 | Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
| US-7316811-B2 | Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2008-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | ABCB4, ABCB1, ZFR | GLA 3646/4885ALDH1A1 2916/4885MAPK1 4461/4885 |
| US-20080248097-A1 | POLYMERIC MICELLES FOR COMBINATION DRUG DELIVERY | MCL1, NUP205, ABCB1 | GLA 3678/4885ALDH1A1 4010/4885MAPK1 3766/4885 |
| US-20080069902-A1 | Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles | INCENP, IAPP, PGF | GLA 2382/4885ALDH1A1 3526/4885MAPK1 3881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.